Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
American Eagle Energy Begins Voluntary Chapter 11 Proceeding
-
Canaccord Genuity Says to Wait for 'Dust to Settle' Around NVIDIA (NVDA) Following Transformation
-
UPDATE: Canaccord Genuity Starts Kempharm (KMPH) at Buy
-
Apple (AAPL) Price Target Lifted to $160 at Canaccord Genuity on iPhone Domination
-
Canaccord Genuity Starts Aduro Biotech (ADRO) at Buy
-
Canaccord Genuity Downgrades HudBay Minerals (HBM) to Hold
-
Natural Grocers by Vitamin Cottage (NGVC) PT Cut at Canaccord Genuity as Comps Fall; Maintains Bullish View
-
Canaccord Genuity Raises PT of Regeneron Pharmaceuticals (REGN) to $525 from $460
-
Aldeyra Therapeutics Announces Pricing of Follow-On Public Offering of Common Stock
-
Orsu Metals Corporation: Directorate Change
-
Dividend 15 Split Corp. II Completes Overnight Offering
-
Canaccord Genuity Downgrades Synageva BioPharma (GEVA) to Hold
-
Shopify to Launch IPO Roadshow
-
Veresen Announces 2015 First Quarter Results and Updated Guidance
-
Canaccord Genuity Upgrades Sandstorm Gold Ltd. (SAND) to Buy
-
ProMetic Announces Closing of $50 M Bought Deal Offering of Common Shares
-
HTG Molecular Diagnostics (HTGM) Prices 3.57M Common IPO at $14/Share
-
HTG Molecular Diagnostics Announces Pricing of Initial Public Offering
-
HTG Molecular Diagnostics Announces Pricing of Initial Public Offering
-
Canaccord Genuity Downgrades Borderfree, Inc. (BRDR) to Hold
-
Dalradian Announces Q1 2015 Results
-
Canaccord Genuity Expands Global REIT Capability with Addition of Dedicated Banking, Equity Research and Sales Professionals in New York and San Francisco
-
Pacific DataVision, Inc. Launches Public Offering of Common Stock
-
Minera IRL Limited: Appointment of Interim CEO and Non-Executive Director and Update on Filing of 31 December 2014 Financial Statements
-
Streetinsider.com's Hot Lunchtime Reads 5/5: (IP) (GOGO) (AR) (HILL)
-
Antero Resources (AR) Taking Advantage of Seasonal Pricing, Canaccord Genuity Says
-
Canaccord Genuity Plays it 'Sensible' with Range Resources (RRC)
-
Notable Analyst Rating Changes 5/5: (NFLX) (ALU) (ARRS) Upgraded; (BIDU) (AOL) (GNW) Downgraded
-
Aldeyra Therapeutics Launches Proposed Follow-on Public Offering of Common Stock
-
Canaccord Genuity Starts Pengrowth Energy Trust (PGH) at Hold
-
Canaccord Genuity Starts Vermilion Energy (VET) at Buy
-
EMED Mining Public Limited: Financing Update and Notice of Results
-
Canaccord Genuity Downgrades Nevsun Resources (NSU) to Hold
-
UPDATE: Canaccord Genuity Downgrades Control4 Corporation (CTRL) to Hold
-
Bioamber (BIOA) Prices 3.9M Common Offering at $9/Share
-
BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering
-
Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR (codeine polistirex and chlorpheniramine polistirex)
-
NephroGenex (NRX) to Offer Up to $30M in Common Stock
-
NephroGenex Announces Proposed Offering of Common Stock
-
BioAmber Inc. Announces Public Offering Of Common Stock
-
Notable Analyst Rating Changes 4/30: (JBLU) (MDLZ) (PGR) Upgraded; (PAG) (BBVA) (OI) Downgraded
-
Pre-Open Stock Movers 04/30: (GLUU) (CKSW) (WX) Higher; (YELP) (INO) (HAR) Lower (more...)
-
Freshpet (FRPT) Prices 5.3M Common Offering at $21.47/Share
-
Canaccord Genuity Downgrades Wi-LAN (WILN) to Hold
-
Canaccord Genuity Downgrades Exactech Inc (EXAC) to Hold
-
Canaccord Genuity Downgrades Agios Pharma (AGIO) to Hold
-
Canaccord Genuity Downgrades Faro Technologies (FARO) to Hold
-
Freshpet, Inc. Announces Pricing of Public Offering by Selling Stockholders
-
Freshpet, Inc. Announces Pricing of Public Offering by Selling Stockholders
-
Lipocine Announces Closing of $34.8 Million Common Stock Offering

